{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-150530","form_type":"8-K","ticker":"CABA","cik":"0001759138","company_name":"Cabaletta Bio, Inc.","filed_at":"2023-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.417375+00:00","generated_at":"2026-06-14T18:23:47.050738+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cabaletta Bio closes $100M public offering of 8.34M shares at $12.00/share","bullets":["Gross proceeds of approximately $100 million from sale of 8,337,500 shares, including full exercise of underwriters' option for 1,087,500 additional shares.","Price of shares was $12.00 per share, before underwriting discounts and commissions.","Joint book-running managers: TD Cowen, Evercore ISI, Guggenheim Securities; lead manager H.C. Wainwright & Co.","Company expects net proceeds plus existing cash to fund operations into Q4 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-150530","json":"https://secwatch.observer/filing/0001193125-23-150530.json","markdown":"https://secwatch.observer/filing/0001193125-23-150530.md","text":"https://secwatch.observer/filing/0001193125-23-150530.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759138/000119312523150530/0001193125-23-150530-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759138/000119312523150530/d470858d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T18:23:47.050738+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}